GLP-1 drugs aren’t just reducing weight — they may also be reducing the chances of developing one of the most common and ...

The story of GLP-1 drugs keeps getting bigger. First they transformed the treatment of diabetes. Then they upended the ...

Women taking GLP-1 drugs 30 percent less likely to develop breast cancer, researchers say - About 42,140 women are expected ...

Women on weight-loss medication may have a lower risk of developing breast cancer, according to a new study. View on euronews ...

A retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who took GLP-1 medications ...

A surprising new study suggests that when it comes to pancreatic cancer, the kind of fat you eat may matter more than how ...

For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug, daraxonrasib, targets the KRAS mutation that fuels most pancreatic ...

Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the ...

An artificial intelligence model from the Mayo Clinic detected early signs of possible pancreatic cancer on scans up to two years before patients were diagnosed.

AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced a significant milestone in its pancreatic cancer development program, with enrollment of the final subject, barring ...